InvestSMART

Cogstate Limited (ASX: CGS) - Announcements

- Current share price for CGS : $3.530

ASX company news and announcements for Cogstate Limited (CGS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cogstate Limited (CGS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cogstate Limited (CGS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cogstate Limited (CGS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$608 Change of Director's Interest Notice - KW 28 Sep 2021 8:53AM $2.400 $3.530 risen by 47.08%
$608 Notice of Annual General Meeting/Proxy Form 23 Sep 2021 8:30AM $2.380 $3.530 risen by 48.32%
$608 2021 AGM Letter to Shareholders and Proxy 23 Sep 2021 8:24AM $2.380 $3.530 risen by 48.32%
$608 Change in substantial holding from AEF 17 Sep 2021 8:53AM $2.000 $3.530 risen by 76.50%
$608 Change of Director's Interest Notice - DD 15 Sep 2021 5:05PM $2.000 $3.530 risen by 76.50%
$608 Change of Director's Interest Notice - MM 15 Sep 2021 5:01PM $2.000 $3.530 risen by 76.50%
$608 Cleansing Statement 10 Sep 2021 5:55PM $1.745 $3.530 risen by 102.29%
$608 Application for quotation of securities - CGS 10 Sep 2021 5:49PM $1.745 $3.530 risen by 102.29%
$608 2021 Annual General Meeting 8 Sep 2021 4:35PM $1.645 $3.530 risen by 114.59%
$608 Change in substantial holding 7 Sep 2021 6:41PM $1.675 $3.530 risen by 110.75%
$608 Investor Presentation - recording available 26 Aug 2021 11:17AM $1.705 $3.530 risen by 107.04%
$608 Investor Briefing 25 Aug 2021 8:49AM $1.745 $3.530 risen by 102.29%
$608 FY21 Financial Results & Business Outlook 25 Aug 2021 8:41AM $1.745 $3.530 risen by 102.29%
$608 Annual Report 25 Aug 2021 8:29AM $1.745 $3.530 risen by 102.29%
$608 Appendix 4E 25 Aug 2021 8:21AM $1.745 $3.530 risen by 102.29%
$608 FY21 Appendix 4G and Corporate Governance Statement 25 Aug 2021 8:08AM $1.745 $3.530 risen by 102.29%
$608 Quarterly Sales Contracts Executed To Date 24 Aug 2021 8:07AM $1.570 $3.530 risen by 124.84%
$608 Financial results and webcast notification 18 Aug 2021 1:29PM $1.550 $3.530 risen by 127.74%
$608 Notification of cessation of securities - CGS 4 Aug 2021 10:02AM $1.650 $3.530 risen by 113.94%
$608 Ceasing to be a substantial holder 27 Jul 2021 2:01PM $1.795 $3.530 risen by 96.66%
$608 July 2021 Investor Presentation 22 Jul 2021 8:19AM $1.435 $3.530 risen by 145.99%
$608 June quarter business update and cashflow report 22 Jul 2021 8:19AM $1.435 $3.530 risen by 145.99%
$608 Value of FY21 Clinical Trials Sales Contracts up 15% 7 Jul 2021 8:29AM $1.400 $3.530 risen by 152.14%
$608 Change in substantial holding 25 Jun 2021 12:23PM $1.480 $3.530 risen by 138.51%
$608 Change in substantial holding from AEF 15 Jun 2021 2:51PM $1.370 $3.530 risen by 157.66%

451 - 475 of 1008 results

Page 19 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.